ResearcherNingxia Hui Autonomous Region Peoples HospitalNo recent work listed

Feihu Bai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4961-1921; OpenAlex author ID A5069105571. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

Zoledronic acid exhibits radio-sensitizing activity in human pancreatic cancer cells via inactivation of STAT3/NF-κB signaling. Last author DOI 10.2147/ott.s202516 ↗
Expression of RUNX3 gene in pancreatic adenocarcinoma and its clinical significance. First author DOI 10.4238/2014.may.23.4 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yanjie You · 1 shared paper, 2019 · strength 0.11
- Paper Zoledronic acid exhibits radio-sensitizing activity in human pancreatic cancer cells via inactivation of STAT3/NF-κB si… DOI 10.2147/ott.s202516 ↗
Yuhong Ma · 1 shared paper, 2019 · strength 0.11
- Paper Zoledronic acid exhibits radio-sensitizing activity in human pancreatic cancer cells via inactivation of STAT3/NF-κB si… DOI 10.2147/ott.s202516 ↗
Kai Xu · 1 shared paper, 2014 · strength 0.05
- Paper Expression of RUNX3 gene in pancreatic adenocarcinoma and its clinical significance. DOI 10.4238/2014.may.23.4 ↗
L.-N. Xue · 1 shared paper, 2014 · strength 0.05
- Paper Expression of RUNX3 gene in pancreatic adenocarcinoma and its clinical significance. DOI 10.4238/2014.may.23.4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.